MedPath

Choline C 11

These highlights do not include all the information needed to use safely and effectively. See full prescribing information for . Initial U.S. Approval: 2012

Approved
Approval ID

e817ab8b-ba2c-4226-b37f-c6d75e4d94cd

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 6, 2019

Manufacturers
FDA

Decatur Memorial Hospital

DUNS: 046584991

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Choline C 11

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code73410-004
Application NumberANDA206319
Product Classification
M
Marketing Category
C73584
G
Generic Name
Choline C 11
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateNovember 6, 2019
FDA Product Classification

INGREDIENTS (2)

SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
CHOLINE C-11Active
Quantity: 4 mCi in 1 mL
Code: M4AS4XGD4Q
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Choline C 11 - FDA Drug Approval Details